Clinical Trial Update: Effect of Intravenous Iron (Ferinject®) on Exercise Capacity and Quality of Life of Stable COPD Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether intravenous iron (Ferinject) improves exercise capacity and quality of life in stable chronic obstructive pulmonary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ferinject (ferric carboxymaltose)

Snippet

Sponsor: Georg-Christian Funk | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: UNKNOWN